scholarly journals Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase

2016 ◽  
Vol 59 (3) ◽  
pp. 329-334 ◽  
Author(s):  
Jeanne Montastruc ◽  
Philippe Marque ◽  
Florence Moulis ◽  
Véronique Bourg ◽  
Valérie Lambert ◽  
...  
Keyword(s):  
Cerebral Palsy ◽  
Epidemiological Study ◽  
Adverse Drug Reactions ◽  
Botulinum Neurotoxin ◽  
Type A ◽  
Drug Reactions ◽  
Botulinum Neurotoxin Type A ◽  
Children With Cerebral Palsy

Spread of Botulinum Neurotoxin Type A at Standard Doses Is Inherent to the Successful Treatment of Spastic Equinus Foot in Cerebral Palsy

2011 ◽  
Vol 27 (5) ◽  
pp. 587-593 ◽  
Author(s):  
Emma Frasson ◽  
Elisa Dall’Ora ◽  
Monia Bordignon ◽  
Francesco Brigo ◽  
Pierluigi Tocco ◽  
...  
Keyword(s):  
Cerebral Palsy ◽  
Successful Treatment ◽  
Botulinum Neurotoxin ◽  
Type A ◽  
Botulinum Neurotoxin Type A

OnabotulinumtoxinA exhibits greater efficacy compared to purified botulinum neurotoxin type A (BoNT/A-150 kDa) in peripheral pain models

Toxicon ◽  
2021 ◽  
Vol 190 ◽  
pp. S70
Author(s):  
Sudhakar R. Subramaniam ◽  
Greg Nicholson ◽  
Brian B. Cai ◽  
Amy D. Brideau-Andersen ◽  
Ron S. Broide
Keyword(s):  
Botulinum Neurotoxin ◽  
Type A ◽  
Botulinum Neurotoxin Type A ◽  
Pain Models ◽  
Peripheral Pain

Real-world treatment intervals with botulinum neurotoxin type A in poststroke spasticity management—Are different formulations different?

Toxicon ◽  
2021 ◽  
Vol 190 ◽  
pp. S63
Author(s):  
Susana Rosa ◽  
Bruno Guimarães ◽  
Joana Martins ◽  
José Luís Mesquita ◽  
Margarida Freitas ◽  
...  
Keyword(s):  
Real World ◽  
Botulinum Neurotoxin ◽  
Type A ◽  
Botulinum Neurotoxin Type A
Sign in / Sign up

Export Citation Format

Share Document